MicroRNA-139-5p suppresses non-small cell lung cancer progression by targeting ATAD2

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• MicroRNA-139-5p (miR-139-5p) is recognized as a tumor suppressor in various cancers.
• Its role in non-small cell lung cancer (NSCLC) remains largely uncharacterized.

Purpose of the Study:

• To investigate the expression and function of miR-139-5p in NSCLC.
• To elucidate the underlying molecular mechanisms, including target genes and signaling pathways involved.

Main Methods:

• Real-time PCR and in situ hybridization (ISH) for miR-139-5p expression analysis.
• In vitro cell culture experiments with miR-139-5p mimic transfection to assess effects on NSCLC cell behavior (proliferation, apoptosis).
• Bioinformatic analysis to predict miR-139-5p targets, followed by experimental validation of ATAD2 and the β-catenin signaling pathway.

Main Results:

• Downregulation of miR-139-5p was observed in NSCLC tissues and cell lines.
• Overexpression of miR-139-5p suppressed NSCLC cell proliferation, induced apoptosis, and inhibited the β-catenin signaling pathway.
• ATAD2 was identified as a direct target of miR-139-5p, and its overexpression counteracted the anti-tumor effects of miR-139-5p.
• Activation of the β-catenin signaling pathway partially reversed the anti-proliferative and pro-apoptotic effects of miR-139-5p.
• In vivo studies demonstrated that miR-139-5p inhibited tumor growth in xenograft models.

Conclusions:

• MiR-139-5p functions as a tumor suppressor in NSCLC.
• Its anti-tumor activity is mediated through the regulation of the oncogene ATAD2 and the β-catenin signaling pathway.
• MiR-139-5p represents a potential therapeutic target for NSCLC treatment.